Host: |
Goat |
Applications: |
Pep-ELISA/WB |
Reactivity: |
Human |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Goat polyclonal antibody anti-Bruno-like 5 (Internal) is suitable for use in ELISA and Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA |
Purification: |
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
Concentration: |
0.5 mg/mL |
Dilution Range: |
WB-1-3µg/mlELISA-antibody detection limit dilution 1:1000. |
Storage Instruction: |
Store at-20°C on receipt and minimise freeze-thaw cycles. |
Gene Symbol: |
CELF5 |
Gene ID: |
60680 |
Uniprot ID: |
CELF5_HUMAN |
Immunogen Region: |
Internal |
Accession Number: |
NP_068757.2 |
Immunogen Sequence: |
EPPGGQPDGMKD |
Function | RNA-binding protein implicated in the regulation of pre-mRNA alternative splicing. Mediates exon inclusion and/or exclusion in pre-mRNA that are subject to tissue-specific and developmentally regulated alternative splicing. Specifically activates exon 5 inclusion of cardiac isoforms of TNNT2 during heart remodeling at the juvenile to adult transition. Binds to muscle-specific splicing enhancer (MSE) intronic sites flanking the alternative exon 5 of TNNT2 pre-mRNA. |
Protein Name | Cugbp Elav-Like Family Member 5Celf-5Bruno-Like Protein 5Cug-Bp- And Etr-3-Like Factor 5Rna-Binding Protein Brunol-5 |
Cellular Localisation | NucleusCytoplasm |
Alternative Antibody Names | Anti-Cugbp Elav-Like Family Member 5 antibodyAnti-Celf-5 antibodyAnti-Bruno-Like Protein 5 antibodyAnti-Cug-Bp- And Etr-3-Like Factor 5 antibodyAnti-Rna-Binding Protein Brunol-5 antibodyAnti-CELF5 antibodyAnti-BRUNOL5 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance